Related Experiment Video
Updated: Jan 19, 2026

Author Spotlight: Enhancing Donor Heart Preservation Through Isolated Rat Heart Perfusion Studies
Published on: October 4, 2024
Pediatric heart transplant from an incompletely treated influenza A-positive donor
Clyde J Smith1, Michael D McCulloch2, Debbie-Ann Shirley3
1Divisions of Critical Care Medicine and Cardiology, Department of Pediatrics, University of Virginia School of Medicine, Charlottesville, Virginia.
Insights
Pediatric heart transplants can proceed even with influenza A infection in donors. Effective antiviral treatments like oseltamivir make influenza A a manageable donor infection, increasing the availability of life-saving organs.
Area of Science:
- Cardiology
- Infectious Diseases
- Transplantation Medicine
Background:
- Pediatric donor heart shortage is critical, with nearly 50% of offered organs declined.
- Concerns about influenza transmission from donors often lead to organ offers being refused.
- Previous success with influenza B-infected donors treated with oseltamivir prompted further investigation.
Observation:
- This report details a successful heart transplant using an organ from an influenza A-positive donor.
- The donor had symptomatic influenza A, with incomplete treatment using oseltamivir.
- The transplant recipient experienced an excellent outcome, similar to prior cases.
Findings:
- Influenza A infection in organ donors, even with symptomatic disease, is manageable.
- Effective antiviral therapies can mitigate the risk of influenza transmission during transplantation.
- Donor organs from influenza A-positive individuals need not be automatically declined.
Implications:
- Expanding the donor pool by accepting influenza A-positive donors can save more children's lives.
- Antiviral treatment protocols for infected donors can increase organ availability for pediatric heart transplantation.
- This study challenges current practices and suggests a re-evaluation of organ acceptance criteria for influenza-infected donors.
Abstract:
There is a shortage of pediatric donor hearts for waitlisted children, and yet nearly 50% of organs offered are not transplanted. Donor quality is often cited as a reason for declining organs offered from donors infected with influenza, presumably due to concern about disease transmission at transplant leading to severe disease. We previously described an excellent outcome after heart transplant from a donor infected with influenza B that had been treated with a complete course of oseltamivir. In this report, we describe a similar outcome after transplantation of an organ from an influenza A-positive donor with symptomatic disease incompletely treated with oseltamivir. Due to the availability of effective antiviral treatment, we suggest that influenza A is also a manageable donor infection that need not preclude heart placement.
Related Concept Videos
06:56Using an Isolated Working Rat Heart Model to Test Donor Heart Preservation Strategies
11:29A Modified Method for Heterotopic Mouse Heart Transplantion
10:56Transplantation of Pulmonary Valve Using a Mouse Model of Heterotopic Heart Transplantation
10:27Murine Heterotopic Heart Transplant Technique
09:48Heterotopic Cervical Heart Transplantation in Mice
14:01Optimization of the Cuff Technique for Murine Heart Transplantation

